Fibromyalgia Trial, Recruiting NCT05443100 Sponsor: Istituto Auxologico Italiano Condition: Fibromyalgia
Back to Fibromyalgia

Fibromyalgia Trial, Recruiting

NCT05443100
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Both men and women are welcome to participate
  • You must be between 18 and 65 years old
  • You must have a BMI (body mass index) greater than 35, which is considered severely obese (confirm with trial site if unsure of your BMI)

Who may not be able to join:

  • People with serious mental health conditions
  • People with an active or recent breathing/lung illness
  • People with an active or recent heart or blood vessel condition
  • People whose blood pressure is not well controlled or is unstable
  • People who have difficulty tolerating cold temperatures
  • People who experience fear of enclosed spaces (claustrophobia)
  • People who are pregnant
  • People who have recently changed their regular medication
  • People who have previously received whole-body cryotherapy (WBC), which is a treatment involving exposure to very cold temperatures (confirm with trial site)
  • People who have lost weight in the last 3 months
  • People who currently have a body temperature higher than 37.5°C (99.5°F), which may indicate a fever

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Paolo Capodaglio, Prof, MD, IRCCS Istituto Auxologico Italiano

Phone: +39 0323514331

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istituto Auxologico Italiano
Registry
ClinicalTrials.gov
Start date
1 April 2019
Est. completion
30 December 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Change from baseline blood catecholamine levels (epinephrine, norepinephrine and dopamine)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov